Will Smegglutide's indications for treating obesity participate in this year's national medical insurance negotiations? Novo Nordisk responded by stating that they will immediately initiate internet access and hospital admissions in various regions
男人的余味偷
发表于 2024-6-25 19:08:19
1231
0
0
On June 25th, the National Medical Products Administration (NMPA) approved the marketing application of Novo Nordisk's Novo Nordisk developed and produced Novo Nordisk's Novo Nordisk Injection (for long-term weight management) in China. Regarding whether the drug will participate in this year's national medical insurance negotiations, Novo Nordisk responded by stating that it will immediately initiate various work such as online listing and hospital medication administration in various regions after Novo Nordisk's approval, in order to help obese patients use this innovative drug for treatment as soon as possible.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
猜你喜欢
- Novo Nordisk's new weight loss oral medication is applying for clinical efficacy or surpassing smeglutide in China
- Longest Clinical Study of Smegglutide Published: Continuous Four Years of Medication Can Maintain 10% Weight Loss
- Can Smegglutide Help Quit Alcohol? Novo Nordisk's latest liver disease research will provide answers
- Novo Nordisk responds that semaglutide may cause male impotence
- Smegglutide has been approved for the treatment of obesity in China, with a supply chain gap of over 70 billion US dollars in the market
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- Will the reduced weight version of Smegglutide be limited in supply to the Chinese market? Novo Nordisk responds
- The Battle of Weight Loss Drugs Begins: Smegglutide's Obesity Indications Approved in China
- Novo Nordisk warns of the risk of compound generic semaglutide, which has caused 10 deaths and 100 hospitalizations
- Weight reducing version of semaglutide officially launched in China
-
知名做空机构香橼研究（Citron Research）周四（11月21日）在社交媒体平台X上发布消息称，该公司已决定做空“比特币大户”微策略（Microstrategy）这家公司，并认为该公司已经将自己变身成为一家比特币投资基金 ...- caffycat
- 昨天 11:18
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯，11月20日，文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍，这是新加坡首个商业化运营的自动驾驶环卫项目。 ...- star8699
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯（记者王子霖）11月20日，斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态，充分发挥主播资源和新业务潜力，持续为用户提供高质量的直播内容及游戏服务，进一步 ...- goodfriendboy
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 （记者栗翘楚、任妍）2024广州车展，在新能源汽车占据“半壁江山”的同时，正加速向智能网联新能源汽车全面过渡，随着“端到端”成为新宠，智能驾驶解决方案成为本届广州车展各大车企竞 ...- 3233340
- 昨天 17:06
- 支持
- 反对
- 回复
- 收藏
